Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
1.490
+0.110 (7.97%)
At close: Nov 22, 2024, 4:00 PM
1.430
-0.060 (-4.03%)
After-hours: Nov 22, 2024, 6:24 PM EST
Compass Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -47.76 | -42.49 | -39.23 | -82.18 | -29.5 | -34.74 | |
| Depreciation & Amortization | 1.86 | 1.89 | 1.9 | 1.62 | 2.4 | 2.12 | |
| Loss (Gain) From Sale of Assets | - | - | -0.07 | -0.04 | 0.28 | - | |
| Asset Writedown & Restructuring Costs | - | - | - | 50.62 | - | - | |
| Loss (Gain) From Sale of Investments | -2.19 | -3.23 | -0.8 | - | - | - | |
| Stock-Based Compensation | 7.92 | 6.12 | 5.33 | 4.03 | 4.02 | 0.92 | |
| Other Operating Activities | - | - | - | 0.04 | 0.65 | 0.22 | |
| Change in Accounts Payable | -1.35 | 0.71 | 2.52 | -0.19 | 0.43 | -1.1 | |
| Change in Other Net Operating Assets | -6.54 | -3.62 | -3.78 | 6.44 | -5.08 | 0.85 | |
| Operating Cash Flow | -48.05 | -40.62 | -34.13 | -19.67 | -26.8 | -31.74 | |
| Capital Expenditures | -0.05 | -0.03 | -0.21 | -1.89 | -0.11 | -0.47 | |
| Sale of Property, Plant & Equipment | - | - | 0.18 | 0.12 | 0.14 | - | |
| Investment in Securities | 37.77 | 27 | -151.16 | - | - | - | |
| Investing Cash Flow | 37.72 | 26.97 | -151.2 | -1.77 | 0.04 | -0.47 | |
| Long-Term Debt Repaid | - | - | - | -9.38 | -5.63 | - | |
| Net Debt Issued (Repaid) | - | - | - | -9.38 | -5.63 | - | |
| Issuance of Common Stock | 18.11 | 3.19 | 76.25 | 128.27 | 60.48 | - | |
| Repurchase of Common Stock | -0.3 | -0.16 | - | - | - | - | |
| Other Financing Activities | -0.54 | -0.09 | -0.5 | -0.28 | -6.32 | - | |
| Financing Cash Flow | 17.27 | 2.94 | 75.76 | 118.61 | 48.54 | - | |
| Net Cash Flow | 6.94 | -10.72 | -109.57 | 97.18 | 21.77 | -32.21 | |
| Free Cash Flow | -48.1 | -40.65 | -34.34 | -21.55 | -26.91 | -32.21 | |
| Free Cash Flow Per Share | -0.36 | -0.32 | -0.33 | -0.34 | -0.87 | -4.81 | |
| Cash Interest Paid | - | - | - | 0.37 | 0.85 | 1.12 | |
| Levered Free Cash Flow | -31.85 | -25.2 | -19.17 | -8.46 | -14.95 | -19.68 | |
| Unlevered Free Cash Flow | -31.85 | -25.2 | -19.17 | -8.23 | -14.38 | -18.91 | |
| Change in Net Working Capital | 6.93 | 1.71 | 0.16 | -7.55 | 3.31 | 0.2 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.